BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

  Total Revenue increased 21%, from $535,334 in Q3 2016 to $646,061

  November 14, 2017

   · 

  20 min read
• Business

  Pertinax Pharma Appoints Nigel Brooksby as Chairman Former Chairman of Sanofi to Help Drive the Commercialization of Pertinax

  Brooksby’s chief responsibilities will be to assist in corporate, strategic and business development moves into its commercialisation phase following the launch last month of Pertinax.

  November 14, 2017

   · 

  3 min read
• Business

  ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

  Net loss for the third quarter of 2017 was $17.0 million, or $0.59 per basic and diluted share.

  November 14, 2017

   · 

  8 min read
• Business

  VBL Therapeutics Announces Third Quarter 2017 Financial Results

  At September 30, 2017, we had cash, cash equivalents and short-term bank deposits totaling $28.2 million and working capital of $24.4 million.

  November 14, 2017

   · 

  9 min read
• Business

  Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights

  As of September 30, 2017, Pluristem had $21.3 million in cash and cash equivalents, bank deposits, restricted deposits and marketable securities.

  November 14, 2017

   · 

  7 min read
• Business

  Deciphera Pharmaceuticals Announces Third Quarter 2017 Financial Results and Corporate Highlights

  As of September 30, 2017, Deciphera Pharmaceuticals reported cash and cash equivalents of $82.1 million.

  November 14, 2017

   · 

  10 min read
• BioCapital

  Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology

  The claims cover small molecule candidates and the family around these candidates and their human use, adding to the patent coverage in the US and elsewhere.

  November 14, 2017

   · 

  2 min read
• American Academy of Ophthalmology Release: Stem Cell Therapy Shows Promise for Common Cause of Blindness

  Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

  November 14, 2017

   · 

  4 min read
• Pharm Country

  Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer

  The BreathScan Alcohol Detector is a proprietary, single-use, non-mechanical device that measures the user’s blood alcohol concentration in approximately 2 minutes, through a simple breath test.

  November 14, 2017

   · 

  4 min read
• Business

  PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year

  Company also improves operating results, reducing operating loss 74% for the third quarter of 2017 from the third quarter of 2016.

  November 14, 2017

   · 

  7 min read